3rd September2015
Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")
Top Ten Equity Holdings and Sector Exposure as at 28- August-15 and full Portfolio listing as at 31-July-15 available from company's website
Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 28th August 2015 the top ten equity holdings and the sector breakdown were as follows:
Top 10 Holdings |
% |
Pfizer |
8.7% |
Novartis |
8.1% |
Roche |
7.1% |
Eli Lilly & Co |
7.0% |
Johnson & Johnson |
5.3% |
AstraZeneca |
4.7% |
Sanofi |
4.4% |
Astellas Pharma |
3.7% |
Merck & Co |
3.6% |
AbbVie |
3.2% |
Total |
55.8% |
Sector Exposure |
% |
Pharmaceuticals |
70.1% |
Healthcare Equipment |
7.4% |
Healthcare Facilities |
5.7% |
Healthcare REITs |
4.3% |
Biotechnology |
4.2% |
Healthcare Services |
2.5% |
Managed Healthcare |
1.7% |
Healthcare Distributors |
1.3% |
Life Sciences Tools & Services |
1.1% |
Healthcare Supplies |
0.7% |
Life & Health Insurance |
0.3% |
Healthcare Technology |
0.3% |
Cash |
0.5% |
Total |
100.0 |
|
|
The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.com
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.